The DOI matches its Crossref record.
Memory and cognitive function in man: Does the cholinergic system have a specific role?
Abstract
Interference with cholinergic function produces disruption of memory/cognitive (M/C) performance in both animals and man. It is uncertain whether this disruption is due to a specific relation of cholinergic neurons to M/C functions, or whether the effect is nonspecific, resulting either from alteration of alertness and attention, or from a "mass action" effect, with loss of functioning neurons. Scopolamine was given to normal subjects to produce an M/C impairment. Half the test subjects then received physostigmine and half d-amphetamine. Physostigmine, a pharmacologic antagonist of scopolamine, markedly improved M/C functions; amphetamine failed to produce M/C improvement, although alertness was improved, and activity in catecholaminergic neurons presumably increased. This comparison supports a specific role for cholinergic neurons in M/C processes. Possible mechanisms of cholinergic neural functioning in memory include plasticity of cholinergic synapses, as well as other acetylcholine-depended operations of the limbic system crucial to memory.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The cholinergic hypothesis of geriatric memory dysfunction
Bartus, R. T., Dean, R. L., Beer, B., & Lippa, A. S. (1982) · Science · doi:10.1126/science.7046051 · Cited by 5,545
Alzheimer's Disease: A Disorder of Cortical Cholinergic Innervation
Coyle, J. T., Price, D. L., & DeLong, M. R. (1983) · Science · doi:10.1126/science.6338589 · Cited by 3,052
Modes and models of forebrain cholinergic neuromodulation of cognition
Hasselmo, M. E., & Sarter, M. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.104 · Cited by 733
Sherwin, B. B. (1988) · Psychoneuroendocrinology · doi:10.1016/0306-4530(88)90060-1 · Cited by 703
A review of chemical issues in 1H NMR spectroscopy: N‐acetyl‐l‐aspartate, creatine and choline
Miller, B. L. (1991) · NMR in Biomedicine · doi:10.1002/nbm.1940040203 · Cited by 654
Brominated flame retardants: a novel class of developmental neurotoxicants in our environment?
Eriksson, P., Jakobsson, E., & Fredriksson, A. (2001) · Environmental Health Perspectives · doi:10.1289/ehp.01109903 · Cited by 585
The significance of the cholinergic system in the brain during aging and in Alzheimer’s disease
Schliebs, R., & Arendt, T. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0579-2 · Cited by 530
Human Serial Learning: Enhancement with Arecholine and Choline Impairment with Scopolamine
Sitaram, N., Weingartner, H., & Gillin, J. C. (1978) · Science · doi:10.1126/science.351808 · Cited by 524
Decker, M. W., & McGaugh, J. L. (1991) · Synapse · doi:10.1002/syn.890070209 · Cited by 524
Revisiting the cholinergic hypothesis in the development of Alzheimer's disease
Craig, L. A., Hong, N. S., & McDonald, R. J. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.03.001 · Cited by 486
Cholinergic modulation of the hippocampal region and memory function
Haam, J., & Yakel, J. L. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14052 · Cited by 450
Changes in the Brain Catecholamines in Patients with Dementia of Alzheimer Type
Adolfsson, R., Gottfries, C. G., Roos, B. E., & Winblad, B. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.135.3.216 · Cited by 449
Neocortical cholinergic innervation: A description of extrinsic and intrinsic components in the rat
Johnston, M. V., McKinney, M., & Coyle, J. T. (1981) · Experimental Brain Research · doi:10.1007/bf00237760 · Cited by 441
Choline transporters, cholinergic transmission and cognition
Sarter, M., & Parikh, V. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1588 · Cited by 400
The Cholinergic Hypothesis: A Historical Overview, Current Perspective, and Future Directions
BARTUS, R. T., DEAN, R. L., PONTECORVO, M. J., & FLICKER, C. (1985) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1985.tb37600.x · Cited by 383
Mobley, W. C., Rutkowski, J. L., Tennekoon, G. I., Gemski, J., Buchanan, K., & Johnston, M. V. (1986) · Molecular Brain Research · doi:10.1016/0169-328x(86)90020-3 · Cited by 380
FLICKER, C., DEAN, R., WATKINS, D., FISHER, S., & BARTUS, R. (1983) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(83)80023-9 · Cited by 370
Physostigmine and Arecoline: Effects of Intravenous Infusions in Alzheimer Presenile Dementia
Christie, J. E., Shering, A., Ferguson, J., & Glen, A. I. M. (1981) · British Journal of Psychiatry · doi:10.1192/bjp.138.1.46 · Cited by 360
Hallanger, A. E., & Wainer, B. H. (1988) · Journal of Comparative Neurology · doi:10.1002/cne.902740403 · Cited by 343
Viberg, H. (2003) · Toxicology and Applied Pharmacology · doi:10.1016/s0041-008x(03)00217-5 · Cited by 340
Animal models of Alzheimer's disease: experimental cholinergic denervation
Smith, G. (1988) · Brain Research Reviews · doi:10.1016/0165-0173(88)90016-1 · Cited by 337
The Pharmacology of Memory: A Neurobiological Perspective
Squire, L. R., & Davis, H. P. (1981) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.21.040181.001543 · Cited by 332
Parsons, C. G., Danysz, W., Dekundy, A., & Pulte, I. (2013) · Neurotoxicity Research · doi:10.1007/s12640-013-9398-z · Cited by 331
Removing Obstacles in Neuroscience Drug Discovery: The Future Path for Animal Models
Markou, A., Chiamulera, C., Geyer, M. A., Tricklebank, M., & Steckler, T. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.173 · Cited by 328
“For example, hypotheses have been proposed regarding the involvement of serotonin and norepinephrine in mood disorders (Schildkraut, 1965; Glowinski and Axelrod, 1965; Coppen, 1967; Bunney and Davis, 1965; Coppen and Doogan, 1988; Caldecott-Hazard et al, 1991; Markou et al, 1998), dopamine dysfunction in schizophrenia…”
Viberg, H. (2003) · Toxicological Sciences · doi:10.1093/toxsci/kfg210 · Cited by 319
Eriksson, P., Viberg, H., Jakobsson, E., Orn, U., & Fredriksson, A. (2002) · Toxicological Sciences · doi:10.1093/toxsci/67.1.98 · Cited by 318
Memory impairment in schizophrenia: its extent, affiliations and neuropsychological character
Tamlyn, D., McKenna, P. J., Mortimer, A. M., Lund, C. E., Hammond, S., & Baddeley, A. D. (1992) · Psychological Medicine · doi:10.1017/s0033291700032773 · Cited by 302
Sunderland, T. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800170032006 · Cited by 298
Forms of memory failure in schizophrenia.
Gold, J. M., Randolph, C., Carpenter, C. J., Goldberg, T. E., & Weinberger, D. R. (1992) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.101.3.487 · Cited by 289
Rossor, M. N. (1982) · The Lancet · doi:10.1016/s0140-6736(82)91212-0 · Cited by 283
Attentional functions of cortical cholinergic inputs: What does it mean for learning and memory?
Sarter, M., Bruno, J. P., & Givens, B. (2003) · Neurobiology of Learning and Memory · doi:10.1016/s1074-7427(03)00070-4 · Cited by 278
Age-Related Changes in Passive Avoidance Retention: Modulation with Dietary Choline
Bartus, R. T., Dean, R. L., Goas, J. A., & Lippa, A. S. (1980) · Science · doi:10.1126/science.7384805 · Cited by 275
Anticholinergics for symptomatic management of Parkinson´s disease
Katzenschlager, R., Sampaio, C., Costa, J., & Lees, A. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003735 · Cited by 259
Brain cholinergic dysfunction and memory in aged rats
LIPPA, A., PELHAM, R., BEER, B., CRITCHETT, D., DEAN, R., & BARTUS, R. (1980) · Neurobiology of Aging · doi:10.1016/0197-4580(80)90019-6 · Cited by 257
Mrzljak, L., Levey, A. I., & Goldman-Rakic, P. S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.11.5194 · Cited by 256
Ball, M. J. (1978) · Acta Neuropathologica · doi:10.1007/bf00690970 · Cited by 254
Lysakowski, A., Wainer, B. H., Bruce, G., & Hersh, L. B. (1989) · Neuroscience · doi:10.1016/0306-4522(89)90180-2 · Cited by 239
Age and fitness effects on EEG, ERPs, visual sensitivity, and cognition
Dustman, R. E., Emmerson, R. Y., Ruhling, R. O., Shearer, D. E., Steinhaus, L. A., Johnson, S. C., Bonekat, H. W., & Shigeoka, J. W. (1990) · Neurobiology of Aging · doi:10.1016/0197-4580(90)90545-b · Cited by 233
Estrogen therapy and cognition: a review of the cholinergic hypothesis
Gibbs, R. B. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0036 · Cited by 206
Increased cognitive sensitivity to scopolamine with age and a perspective on the scopolamine model
Molchan, S. E., Martinez, R. A., Hill, J. L., Weingartner, H. J., Thompson, K., Vitiello, B., & Sunderland, T. (1992) · Brain Research Reviews · doi:10.1016/0165-0173(92)90017-g · Cited by 187
Giessel, A. J., & Sabatini, B. L. (2010) · Neuron · doi:10.1016/j.neuron.2010.09.004 · Cited by 156
Effects of cholinergic drugs on delayed match-to-sample performance of rhesus monkeys
Penetar, D. M., & McDonough, J. H. (1983) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(83)90399-4 · Cited by 96
Fields, R. B., Van Kammen, D. P., Peters, J. L., Rosen, J., Van Kammen, W. B., Nugent, A., Stipetic, M., & Linnoila, M. (1988) · Schizophrenia Research · doi:10.1016/0920-9964(88)90024-2 · Cited by 88
“While the link between memory functioning and the cholinergic system is well known (Drachman, 1977) the present results are consistent with other research which suggests a role for the noradrenergic system in memory as well.”
ResultDecker, M. W., Bannon, A. W., Curzon, P., Gunther, K. L., Brioni, J. D., Holladay, M. W., Lin, N.-H., Li, Y., Daanen, J. F., Buccafusco, J. J., et al. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37015-6 · Cited by 88
The septo-hippocampal system, learning and recovery of function
Niewiadomska, G., Baksalerska-Pazera, M., & Riedel, G. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.03.039 · Cited by 67
“By contrast, boosting central cholinergic function improved the performance of aged patients with cholinergic hypoactivity (Drachman, 1977).”
Cholinergic Control in Developing Prefrontal–Hippocampal Networks
Janiesch, P. C., Krüger, H.-S., Pöschel, B., & Hanganu-Opatz, I. L. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.2644-11.2011 · Cited by 49
Ankarberg, E., Fredriksson, A., & Eriksson, P. (2001) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00207-8 · Cited by 45
Johnson, B. A., Roache, J. D., Ait-Daoud, N., Wallace, C., Wells, L. T., & Wang, Y. (2005) · Psychopharmacology · doi:10.1007/s00213-004-1998-0 · Cited by 33
Main plant extracts’active properties effective on scopolamine-induced memory loss
Balmus, I.-M., & Ciobica, A. (2017) · American Journal of Alzheimer's Disease & Other Dementiasr · doi:10.1177/1533317517715906 · Cited by 25
Metadata
- Authors
- DRACHMAN, D. A.
- Venue
- Neurology
- Published
- 1977-08
- Volume
- 27
- Issue
- 8
- Pages
- 783-783
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2040340862
- Cited by
- 614
- References
- 0
- FWCI
- 13.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.